Cargando…

Hedgehog Inhibitors Suppress Osteoclastogenesis in In Vitro Cultures, and Deletion of Smo in Macrophage/Osteoclast Lineage Prevents Age-Related Bone Loss

The functional role of the Hedgehog (Hh)-signaling pathway has been widely investigated in bone physiology/development. Previous studies have, however, focused primarily on Hh functions in bone formation, while its roles in bone resorption have not been fully elucidated. Here, we found that cyclopam...

Descripción completa

Detalles Bibliográficos
Autores principales: Kohara, Yukihiro, Haraguchi, Ryuma, Kitazawa, Riko, Imai, Yuuki, Kitazawa, Sohei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216259/
https://www.ncbi.nlm.nih.gov/pubmed/32326611
http://dx.doi.org/10.3390/ijms21082745
_version_ 1783532377533841408
author Kohara, Yukihiro
Haraguchi, Ryuma
Kitazawa, Riko
Imai, Yuuki
Kitazawa, Sohei
author_facet Kohara, Yukihiro
Haraguchi, Ryuma
Kitazawa, Riko
Imai, Yuuki
Kitazawa, Sohei
author_sort Kohara, Yukihiro
collection PubMed
description The functional role of the Hedgehog (Hh)-signaling pathway has been widely investigated in bone physiology/development. Previous studies have, however, focused primarily on Hh functions in bone formation, while its roles in bone resorption have not been fully elucidated. Here, we found that cyclopamine (smoothened (Smo) inhibitor), GANT-58 (GLI1 inhibitor), or GANT-61 (GLI1/2 inhibitor) significantly inhibited RANKL-induced osteoclast differentiation of bone marrow-derived macrophages. Although the inhibitory effects were exerted by cyclopamine or GANT-61 treatment during 0–48 h (early stage of osteoclast differentiation) or 48–96 h (late stage of osteoclast differentiation) after RANKL stimulation, GANT-58 suppressed osteoclast formation only during the early stage. These results suggest that the Smo-GLI1/2 axis mediates the whole process of osteoclastogenesis and that GLI1 activation is requisite only during early cellular events of osteoclastogenesis. Additionally, macrophage/osteoclast-specific deletion of Smo in mice was found to attenuate the aging phenotype characterized by trabecular low bone mass, suggesting that blockage of the Hh-signaling pathway in the osteoclast lineage plays a protective role against age-related bone loss. Our findings reveal a specific role of the Hh-signaling pathway in bone resorption and highlight that its inhibitors show potential as therapeutic agents that block osteoclast formation in the treatment of senile osteoporosis.
format Online
Article
Text
id pubmed-7216259
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-72162592020-05-22 Hedgehog Inhibitors Suppress Osteoclastogenesis in In Vitro Cultures, and Deletion of Smo in Macrophage/Osteoclast Lineage Prevents Age-Related Bone Loss Kohara, Yukihiro Haraguchi, Ryuma Kitazawa, Riko Imai, Yuuki Kitazawa, Sohei Int J Mol Sci Article The functional role of the Hedgehog (Hh)-signaling pathway has been widely investigated in bone physiology/development. Previous studies have, however, focused primarily on Hh functions in bone formation, while its roles in bone resorption have not been fully elucidated. Here, we found that cyclopamine (smoothened (Smo) inhibitor), GANT-58 (GLI1 inhibitor), or GANT-61 (GLI1/2 inhibitor) significantly inhibited RANKL-induced osteoclast differentiation of bone marrow-derived macrophages. Although the inhibitory effects were exerted by cyclopamine or GANT-61 treatment during 0–48 h (early stage of osteoclast differentiation) or 48–96 h (late stage of osteoclast differentiation) after RANKL stimulation, GANT-58 suppressed osteoclast formation only during the early stage. These results suggest that the Smo-GLI1/2 axis mediates the whole process of osteoclastogenesis and that GLI1 activation is requisite only during early cellular events of osteoclastogenesis. Additionally, macrophage/osteoclast-specific deletion of Smo in mice was found to attenuate the aging phenotype characterized by trabecular low bone mass, suggesting that blockage of the Hh-signaling pathway in the osteoclast lineage plays a protective role against age-related bone loss. Our findings reveal a specific role of the Hh-signaling pathway in bone resorption and highlight that its inhibitors show potential as therapeutic agents that block osteoclast formation in the treatment of senile osteoporosis. MDPI 2020-04-15 /pmc/articles/PMC7216259/ /pubmed/32326611 http://dx.doi.org/10.3390/ijms21082745 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kohara, Yukihiro
Haraguchi, Ryuma
Kitazawa, Riko
Imai, Yuuki
Kitazawa, Sohei
Hedgehog Inhibitors Suppress Osteoclastogenesis in In Vitro Cultures, and Deletion of Smo in Macrophage/Osteoclast Lineage Prevents Age-Related Bone Loss
title Hedgehog Inhibitors Suppress Osteoclastogenesis in In Vitro Cultures, and Deletion of Smo in Macrophage/Osteoclast Lineage Prevents Age-Related Bone Loss
title_full Hedgehog Inhibitors Suppress Osteoclastogenesis in In Vitro Cultures, and Deletion of Smo in Macrophage/Osteoclast Lineage Prevents Age-Related Bone Loss
title_fullStr Hedgehog Inhibitors Suppress Osteoclastogenesis in In Vitro Cultures, and Deletion of Smo in Macrophage/Osteoclast Lineage Prevents Age-Related Bone Loss
title_full_unstemmed Hedgehog Inhibitors Suppress Osteoclastogenesis in In Vitro Cultures, and Deletion of Smo in Macrophage/Osteoclast Lineage Prevents Age-Related Bone Loss
title_short Hedgehog Inhibitors Suppress Osteoclastogenesis in In Vitro Cultures, and Deletion of Smo in Macrophage/Osteoclast Lineage Prevents Age-Related Bone Loss
title_sort hedgehog inhibitors suppress osteoclastogenesis in in vitro cultures, and deletion of smo in macrophage/osteoclast lineage prevents age-related bone loss
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216259/
https://www.ncbi.nlm.nih.gov/pubmed/32326611
http://dx.doi.org/10.3390/ijms21082745
work_keys_str_mv AT koharayukihiro hedgehoginhibitorssuppressosteoclastogenesisininvitroculturesanddeletionofsmoinmacrophageosteoclastlineagepreventsagerelatedboneloss
AT haraguchiryuma hedgehoginhibitorssuppressosteoclastogenesisininvitroculturesanddeletionofsmoinmacrophageosteoclastlineagepreventsagerelatedboneloss
AT kitazawariko hedgehoginhibitorssuppressosteoclastogenesisininvitroculturesanddeletionofsmoinmacrophageosteoclastlineagepreventsagerelatedboneloss
AT imaiyuuki hedgehoginhibitorssuppressosteoclastogenesisininvitroculturesanddeletionofsmoinmacrophageosteoclastlineagepreventsagerelatedboneloss
AT kitazawasohei hedgehoginhibitorssuppressosteoclastogenesisininvitroculturesanddeletionofsmoinmacrophageosteoclastlineagepreventsagerelatedboneloss